Finance

Lists
Why is CCEL up 5.21%?
Dive Deeper
CCEL:NYSEAMERICAN
Cryo-Cell International Inc
$4.24
+5.21%
(+0.21) 1D
Sep 25, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CCEL...
Open
$4.24
High
$4.24
Low
$4.24
Mkt. cap
34.19M
Avg. vol.
16.51K
Volume
330.00
52-wk high
$4.93
52-wk low
$2.72
EPS
-$0.31
Beta
0.06
Shares outstanding
8.06M
No. of employees
74
Open
$4.24
High
$4.24
Low
$4.24
Mkt. cap
34.19M
Avg. vol.
16.51K
Volume
330.00
52-wk high
$4.93
52-wk low
$2.72
EPS
-$0.31
Beta
0.06
Shares outstanding
8.06M
No. of employees
74
Profile
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL. Wikipedia
About Cryo-Cell International Inc
CEOMark L. Portnoy | David I. Portnoy
Employees74
Founded1989
HeadquartersOldsmar, Florida, United States
SectorHealth care provider
Websitecryo-cell.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
7.83M
7.84M
7.68M
7.78M
Cost of goods sold
1.80M
6.09M
1.66M
1.68M
Cost of revenue
1.80M
6.09M
1.66M
1.68M
Research and development expenses
61.62K
84.78K
65.76K
99.78K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.88M
5.45M
5.01M
4.62M
Operating expense
4.12M
5.72M
5.26M
4.90M
Total operating expenses
5.92M
11.81M
6.92M
6.58M
Operating income
1.90M
-3.97M
765.13K
1.20M
Other non operating income
17.56K
18.41K
8.34K
338.00
EBT including unusual items
1.19M
-4.63M
70.31K
827.78K
EBT excluding unusual items
1.38M
-4.43M
310.77K
755.76K
Income tax expense
436.59K
-814.54K
23.20K
273.20K
Effective tax rate
36.81%
17.59%
33.00%
33.00%
Other operating expenses
-
-
-
-
Net income
749.41K
-3.82M
47.11K
554.59K
Net profit margin
9.58%
-48.67%
0.61%
7.13%
Earnings per share
0.10
-0.47
0.02
0.07
Interest and investment income
-
-
-
-
Interest expense
-538.22K
-481.95K
-462.71K
-441.92K
Net interest expenses
-538.22K
-481.95K
-462.71K
-441.92K
Depreciation and amortization charges
185.69K
183.83K
183.89K
184.33K
EBITDA
2.14M
-3.72M
1.01M
1.44M
Gain or loss from assets sale
633.00
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps